mRNA platform verified with product approval
Argentina – IRS Approval for FATCA Agreement with United States
–Big milestone achieved with fruquintinib successfully approved by US FDA
Expect strong sales in 2023 driven by the US approval of zanubrutinib in CLL
Targeted Modification Of Streamlined Procedures For Approval Of Successor Flexible Credit Line And Precautionary And Liquidity Line Arrangements
mRNA vaccine approved
–Eyes on the FDA approval of fruquintinib in Nov
公众号
小程序
社群
公众号小程序社群